期刊文献+

戈谢病Ⅲ型同胞患儿临床及GBA基因突变分析 被引量:6

Clinical features and GBA gene mutation in two siblings with type Ⅲ Gaucher disease
下载PDF
导出
摘要 目的探讨戈谢病Ⅲ型的临床表现、脑电图特点及致病基因突变。方法分析戈谢病Ⅲ型-家系中姐弟2例同胞患儿的临床资料,以及采用PCR-直接测序方法检测的患儿及其父母外周血白细胞β-葡糖苷酶GBA基因结果。结果先证者,弟弟,9岁,肝脾显著肿大,血小板减少(68×109/L),无神经系统症状,智力、运动正常,脑电图异常,醒睡各期广泛性中低波幅棘慢波、多棘慢波频繁阵发,清醒期放电明显。白细胞β-葡糖苷酶活性显著降低(1.5 nmol·h-1·mg-1Pr),符合戈谢病Ⅲ型。姐姐,12岁,自7岁起反复癫痫发作,呈强直阵挛、肌阵挛表现,多种抗癫痫药物治疗效果差,伴语言、智力、运动倒退,病情进行性加重,肝肋下2.5 cm,脾脏无肿大,脑电图显示多灶异常放电,并频繁泛化全导,白细胞β-葡糖苷酶活性亦显著降低(1.8 nmol·h-1·mg-1 Pr)。两例患儿的GBA基因突变相同,为c.680A>G(p.N188S)/c.1342G>C(p.D409H),分别来自其父母。结论两例同胞患儿具有相同的基因突变,但临床表现差异显著,可能随着病情进展症状加重。戈谢病Ⅲ型为慢性神经病变型,以神经系统症状如癫痫发作、肌阵挛等为主要表现起病,肝脾肿大及脾功能亢进可不显著。 Objective To report clinical manifestations, electroencephalogram(EEG), and the genotypes of two siblings with type Ⅲ Gaucher disease. Methods Two patients with different features were siblings. Their clinical data, signs, peripheral leukocytes acid β-glucosidase activity, and GBA gene were analyzed. Results(1) The proband was a boy. He visited us at the age of nine years old because of hepatosplenomegaly, thrombocytopenia and growth retardation without any neurologic symptoms. He had normal intelligence but abnormal EEG findings. The activity of acid β-glucosidase in his leucocytes decreased to 1.5 nmol h^-1·mg^-1 Pr(normal range 6.0-16.7 nmol h^-1·mg^-1 Pr), supporting the diagnosis of type Ⅲ Gaucher disease.(2) The elder sister of the proband was 12 years old. She had tonic-clonic seizure and myoclonus seizure from the age of seven years old. Mild hepatomegaly, abnormal EEG, poor effect for antiepileptics, and progressive deterioration of psychomotor abilities were found. Her blood leucocytes acid β-glucosidase activity decreased to 1.8 nmol h^-1·mg^-1 Pr(normal range 6.0-16.7 nmol h^-1·mg^-1 Pr). Two heterozygous missense mutations, c.680A〉G,(p.N188S) and c.1342G〉C(p.D409H) were detected from the two siblings, respectively. Conclusions Patients with type Ⅲ Gaucher disease usually have the onset in childhood with typical features of Gaucher disease without neurologic involvement. Abnormal EEG may be helpful to the differential diagnosis of type I or type Ⅲ. On the other hand, neurologic manifestations could be presented as the first symptom in some patients without viscera enlargement. The patients of type Ⅲ Gaucher disease with the same genotype could have different phenotypes, even between the siblings.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2015年第5期462-465,共4页 Journal of Clinical Pediatrics
关键词 戈谢病 Β-葡糖苷酶 癫痫 溶酶体贮积症 GBA基因 Gaucher disease β-glucosidase hepatosptenomegaly epilepsy GBA gene
  • 相关文献

参考文献12

  • 1Beufler E, Gradowski OK. Gaucher disease [M]//Seriver CR, Beaudet A, Sly WS, et al. The metabolic and molecular bases of inherited disease. 8e eds. New York: MeGraw. Hil. 2001.
  • 2Charrow J, Andersson HC, Kaplan P, et al. The Gaucher registry., demographics and disease characteristics of 1698 patients with Gaucher disease [J]. Arch Intern Med, 2000, 160(18).. 2835-2843.
  • 3段彦龙,张永红,臧晏,施惠平,张为民,胡亚美.酶替代治疗戈谢病72例[J].中华儿科杂志,2006,44(9):653-656. 被引量:35
  • 4张为民,邓亮生,孟岩,姚凤霞,邱正庆,段彦龙,黄尚志,施惠平.中国人戈谢病基因突变的分析[J].中华医学杂志,2009,89(48):3397-3400. 被引量:35
  • 5Koprivica V, Stone DL, Park JK, et aL Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease [J]. Am J Hum Genet, 2000, 66(6): 1777-1786.
  • 6Kim JW, Liou BB, Lai MY, et al. Gaucher disease: identification of three new mutations in the Korean and Chinese (Taiwan Residents) populations [J]. Hum Mutat, 1996, 7(3): 214-218.
  • 7Pastores GM, Hughes DA. Gaucher Disease [M/OL]//Pa- gon RA, Bird TC, Dolan CR, et aL GeneReviews. http: //www.ncbi.nlm.nih.gov/books/.
  • 8Park J-K, Orvisky E, Tayebi N, et al. Myoclonic epilepsy in gaucher disease: genotype-phenotype insights from a rare patient subgroup[J].PediatrRes, 2003, 53(3): 387-395.
  • 9Manganotfi P, Tamburin S, Zanette G, et aL Hyperexcit- able cortical responses in progressive myoclonic epilepsy: aTMS study [J]. Neurology, 2001, 57(10). 1793-1799.
  • 10Abrahamov A, Elstein D, Horowitz M, et al. A new Gaucher disease variant characterized by progressive calci- fication of heart valves and unique genotype [J]. Lancet, 1995, 346(8981): 1000-1003.

二级参考文献24

  • 1Beutler E, Gradowski GA. Gaucher disease. In : Scriver CR, Beaudet AL, Sly WS, et al, ed. The metabolic and molecular bases of inherited disease. 8^th ed. New York: McGraw-Hill, 2001:3635-3668.
  • 2Choy FYM, Humphrise ML, Shi HP. Identification of two novel and four uncommon missense mutation among Chinese Gaucher disease patients. Am J Med Genet, 1997, 71 : 172-178.
  • 3Choy FYM, Wong K, Shi HP. Glucocerebrosidase mutations among Chinese neuronopathic Gaucher disease patients. Am J Med Genet, 1999, 74: 484-486.
  • 4Devost NC, Choy FYM, Shi HP. Mutation analysis of Gaucher disease using dot-blood samples on FTA filter paper. Am J Med Genet, 2000,94 : 417-420.
  • 5Tang NL, Zhang W, Grabowski GA, et al. Novel mutateon in type 2 Gaucher disease in Chinese and their functional characterization by heterologous expression. Hum Murat, 2005, 26: 59-60.
  • 6Choy FY, Zhang W, Shi HP, et al. Gaucher disease among Chinese patients : review on genotype/phenoltype correlateion from 29 patients and identification of novel and rare alleles. Blood Cell Mol Dis, 2007. 38: 287-293.
  • 7Tang NL, Zhang W, Grabowski GA, et al. Spectrum of mutations in 50 Chinese Gaucher patients: evideuce of ethnic-specific mutation. ( manuscript submitted).
  • 8Hiroyuki Ida, Rennert OM, Iwasawa K, et al. Clinical and genetic studies of Japanese homozygotes for the Gaucher disease L444P mutation. Hum Genet , 1999,105 : 120-126.
  • 9Kathleen S, Hruska A. Gaucher disease: Mutation and polymorphism spectrum in the glucocerebrosidase gene ( GBA). Hum Mutat,2008, 29:567-583.
  • 10胡亚美 江载芳 陆华 申昆玲 左启华 李同 等.实用儿科学(第7版)[M].北京:人民卫生出版社,2002.698-705.

共引文献57

同被引文献27

  • 1段彦龙,张永红,臧晏,施惠平,张为民,胡亚美.酶替代治疗戈谢病72例[J].中华儿科杂志,2006,44(9):653-656. 被引量:35
  • 2NAGRAL A.Gaucher disease[J].Journal of clinical and experimental hepatology,2014,4(1):37-50.doi:10.1016/j.jceh.
  • 3KOMNINAKA V,KOLOMODI D,CHRISTOULAS D,et al.Evaluation of bone involvement in patients with Gaucher disease:a semiquantitative magnetic resonance imaging method(using ROI estimation of bone lesion)as an alternative method to semi-quantitative methods used so far[J].European journal of haematology,2015,95(4):342-351.doi:10.1111/ejh.12504.
  • 4THOMAS A S,MEHTA A,HUGHES D A.Gaucher disease:haematological presentations and complications[J].British journal of haematology,2014,165(4):427440.doi:10.1111/bjh.12804.
  • 5KAMATH R S,LUKINA E,WATMAN N,et al.Skeletal improvement in patients with Gaucher disease type 1:a phase 2 trial of oral eliglustat[J].Skeletal radiology,2014,43(10):1353-1360.doi:10.1007/s00256-014-1891-9.
  • 6DANDANA A,BEN KHELIFA S,CHAHED H,et al.Gaucher disease:clinical,biological and therapeutic aspects[J].Pathobiology:journal of immunopathology,molecular and cellular biology,2016,83(1):13-23.doi:10.1159/000440865.
  • 7ROSENBAUM H.Hemorrhagic aspects of Gaucher disease[J].Rambam Maimonides Medical Journal,2014,5(4):e0039.doi:10.5041/rmmj.10173.
  • 8LINARl S,CASTAMAN G.Hematological manifestations and complications of Gaucher disease[J].Expert review of hematology,2016,9(1):51-58.doi:10.1586/17474086.2016.1112732.
  • 9ZIMMERMANN A,GRIGORESCU-SIDO P,ROSSMANN H,et al.Dynamic changes of lipid profile in Romanian patients with Gaucher disease type 1 under enzyme replacement therapy:a prospective study[J].Journal of Inherited Metabolic Disease,2013,36(3):555-563.doi:10.1007/s10545-012-9529-3.
  • 10STEIN P,YANG R,LIU J,et al.Evaluation of high density lipoprotein as a circulating biomarker of Gaucher disease activity.[J]Inherit Metab Dis,2011,34:429437.doi:10.1007/s10545-010-9271-7.

引证文献6

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部